Literature DB >> 23903207

Towards a prevention model of health care.

Alasdair Breckenridge1, Hans-Georg Eichler.   

Abstract

Mesh：

Year:  2013        PMID： 23903207     DOI： 10.1038/nrd4077

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  3 in total

1.  New horizons in pharmaceutical regulation.

Authors:  Alasdair Breckenridge; Michelle Mello; Bruce M Psaty
Journal:  Nat Rev Drug Discov       Date:  2012-06-29       Impact factor: 84.694

2.  Treatment options for rheumatoid arthritis beyond TNF-α inhibitors.

Authors:  Yusuf Yazici; Ismail Simsek
Journal:  Expert Rev Clin Pharmacol       Date:  2010-09       Impact factor: 5.045

Review 3.  The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2 therapy and personalized medicine.

Authors:  Jeffrey S Ross; Elzbieta A Slodkowska; W Fraser Symmans; Lajos Pusztai; Peter M Ravdin; Gabriel N Hortobagyi
Journal:  Oncologist       Date:  2009-04-03
  3 in total
  1 in total

Review 1.  European perspective for effective cancer drug development.

Authors:  Denis Lacombe; Sabine Tejpar; Roberto Salgado; Fatima Cardoso; Vassilis Golfinopoulos; Daniela Aust; Gunnar Folprecht; Arnaud Roth; Roger Stupp
Journal:  Nat Rev Clin Oncol       Date:  2014-06-17       Impact factor: 66.675
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.